Where imaging flow cytometry earns its cost: the questions a picture of every event answers that a scatter plot cannot, what the imaging costs in throughput and sensitivity, and the controls an image based gate still needs

What the image actually buys

1. Internalisation, which intensity cannot distinguish. A labelled ligand bound to the surface and one taken into the cell give similar total intensity and completely different biology. An image resolves it directly, and this is the application where imaging cytometry most clearly beats the alternatives.
2. Colocalisation, on thousands of events rather than dozens. Whether two markers occupy the same compartment is a microscopy question answered on a handful of cells. An imaging cytometer answers it with the statistics of a cytometry experiment, which is a genuinely different kind of evidence.
3. Nuclear translocation as a measured quantity. Similarity between a transcription factor's signal and a nuclear stain gives a per-cell translocation score across the whole population, rather than a qualitative impression from selected fields.
4. Doublets, debris and morphology, settled by looking. Scatter based doublet exclusion is inference; an image is evidence. For samples where aggregation is a real problem, being able to see what was gated is worth a great deal of argument avoided.
5. Accept the cost in throughput and sensitivity. Acquisition is slower than a conventional analyser and detector sensitivity is generally lower, so a dim marker that works on a conventional instrument may not work here. Run the panel on the actual instrument before committing a study to it.

Data volume and analysis

Storing an image of every channel for every event produces files far larger than conventional cytometry, and the analysis is image analysis rather than gating. Plan storage and the analysis skills before the instrument arrives.

The feature set the software computes is the analysis, so understanding what each feature measures matters more than the gating strategy. A feature applied without understanding produces a number that looks like a measurement.

Buying against core access

These instruments are expensive, slower to run and need an experienced operator, which makes them a classic core facility instrument. For intermittent work, access plus expert help usually gives better data than ownership.

Buy when the imaging question is continuous and somebody's role includes running it. As with any specialised instrument, the operator is the real purchase.

Designing a panel for it

Leave a channel for a brightfield image and one for a nuclear stain: both are what the image analysis depends on, and a panel that uses every detector for markers gives up the instrument's advantage.

Titrate on this instrument rather than carrying titres over from a conventional analyser. Detection differs, and a reagent titrated elsewhere is not titrated here.

An igg2a antibody and the isotype control question

An igg2a antibody is often bought as an isotype control, and a control is only useful when it matches the test antibody's isotype, host, conjugate and concentration, which is why the control is chosen after the primary rather than from stock. Isotype controls report non specific binding, not gating, and they are not a substitute for an unstained or a knockout control.

An anti-human fc antibody and what it detects

An anti-human fc antibody detects the constant region of human immunoglobulin, which is how a therapeutic antibody or an Fc fusion is measured on cells and in an assay, and it cross reacts with any human immunoglobulin in the sample. For a serum measurement that is the whole difficulty, and an anti-idiotype reagent is what gives specificity instead.

An hla-abc antibody and the class I complex

An hla-abc antibody detects a shared determinant on the class I molecules rather than one allele, so it reports the presence of the complex and its loss, which is the readout in immune evasion work. Surface expression needs the peptide loading machinery, so a low signal may be a processing defect rather than a transcriptional one, and that distinction belongs in the interpretation.

A cd3 zeta antibody and the chain that signals

CD3 zeta carries the signalling motifs of the receptor complex, so a cd3 zeta antibody is read as phosphorylation after stimulation rather than as a surface level, and it is also the domain engineered into receptor constructs. Its level falls in chronic stimulation, which is itself a finding. A phospho clone naming its motif is the measurement.

An nkg2c antibody and the activating counterpart

NKG2C is the activating receptor whose inhibitory relative shares a partner chain, so an nkg2c antibody must be specific against NKG2A for the panel to mean anything, and the expanded population it marks is the reason the panel exists. A deletion polymorphism means some donors express none, which is the control a surprising result should be checked against.

A cd122 antibody and the shared receptor chain

CD122 is the beta chain shared by two cytokine receptors, so a cd122 antibody reports a chain rather than a receptor and the partner chain decides which cytokine the cell responds to. It marks memory and NK populations, and its level rises with activation, so the resting control is part of the measurement rather than an extra.

An estrogen receptor beta antibody and a difficult target

Antibodies against the beta receptor have a poor specificity record and several widely used clones did not survive knockout tissue, so an estrogen receptor beta antibody needs that validation rather than a peptide block. Expression is low where it matters, and the alpha receptor is abundant in the same tissues, which is the cross reactivity that ruins a result.

An mre11 antibody and the complex it belongs to

MRE11 is the nuclease of a three subunit repair complex, so an mre11 antibody is bought with the others for a colocalisation or a pulldown rather than alone, and the subunits destabilise each other, so knocking one down lowers the rest. Recruitment to damage over a time course rather than a level is the readout.

Common questions

What does imaging flow cytometry do that conventional cytometry cannot?

It captures an image of every event, so internalisation, colocalisation, nuclear translocation and morphology become measurable across a whole population rather than inferred from intensity or observed on a few cells.

Is it slower than a conventional analyser?

Yes, substantially, and that is the main practical cost alongside the data volume. For a panel that needs only intensity, a conventional analyser is faster, more sensitive and cheaper to run.

Can it replace a microscope?

No. Spatial resolution is far lower than a microscope's and there is no tissue context. It replaces the need to do microscopy on thousands of cells to get a population statistic.

Do I still need the usual controls?

All of them. Single stained controls for compensation, unstained cells, and a viability dye, exactly as on a conventional instrument. An image does not remove spectral spillover.

Browse by service class

• Compare Gene synthesis on advertised prices